Abstract
BackgroundTransforming growth factor beta (TGFβ) cytokines (TGFβ1, TGFβ2, and TGFβ3) play critical roles in tissue fibrosis.[1] However, treating fibrotic diseases with systemic pan-TGFβ inhibitors has demonstrated unacceptable toxicities.[2,3] In human...
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have